Findings suggest that IL8 (show IL8 Antibodies)-dependent osteoclast activation may constitute an early event in the initiation of the joint specific inflammation in anti-citrullinated protein-positive rheumatoid arthritis.

these data outline a novel role for the P2Y6 receptor (show P2RY6 Antibodies) in the induction of CXCL8/IL-8 (show IL8 Antibodies) production and barrier dysfunction in response to C. difficile toxin exposure and may provide a new therapeutic target for the treatment of CDI.

these data suggest that IL-8 (show IL8 Antibodies) plays an important role in breast cancer osteolysis